» Articles » PMID: 34356883

Hexapod Assassins' Potion: Venom Composition and Bioactivity from the Eurasian Assassin Bug

Overview
Journal Biomedicines
Date 2021 Aug 6
PMID 34356883
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Assassin bug venoms are potent and exert diverse biological functions, making them potential biomedical goldmines. Besides feeding functions on arthropods, assassin bugs also use their venom for defense purposes causing localized and systemic reactions in vertebrates. However, assassin bug venoms remain poorly characterized. We collected the venom from the assassin bug and investigated its composition and bioactivity in vitro and in vivo. It caused lysis of murine neuroblastoma, hepatoma cells, and healthy murine myoblasts. We demonstrated, for the first time, that assassin bug venom induces neurolysis and suggest that it counteracts paralysis locally via the destruction of neural networks, contributing to tissue digestion. Furthermore, the venom caused paralysis and melanization of larvae and pupae, whilst also possessing specific antibacterial activity against , but not and . A combinatorial proteo-transcriptomic approach was performed to identify potential toxins responsible for the observed effects. We identified neurotoxic Ptu1, an inhibitory cystin knot (ICK) toxin homologous to ω-conotoxins from cone snails, cytolytic redulysins homologous to trialysins from hematophagous kissing bugs, and pore-forming hemolysins. Additionally, chitinases and kininogens were found and may be responsible for insecticidal and cytolytic activities. We demonstrate the multifunctionality and complexity of assassin bug venom, which renders its molecular components interesting for potential biomedical applications.

Citing Articles

Antischistosomal Potential of Animal-Derived Natural Products and Compounds.

Fischer-Carvalho A, Taveira-Barbosa T, Verjovski-Almeida S, Haeberlein S, Sena Amaral M Microorganisms. 2025; 13(2).

PMID: 40005763 PMC: 11858059. DOI: 10.3390/microorganisms13020397.


Venom exaptation and adaptation during the trophic switch to blood-feeding by kissing bugs.

Zdenek C, Cardoso F, Robinson S, Mercedes R, Raidjoe E, Hernandez-Vargas M iScience. 2024; 27(9):110723.

PMID: 39280617 PMC: 11402303. DOI: 10.1016/j.isci.2024.110723.


Recent Advances in the Discovery of Novel Drugs on Natural Molecules.

Quintieri L, Caputo L, Nicolotti O Biomedicines. 2024; 12(6).

PMID: 38927461 PMC: 11200856. DOI: 10.3390/biomedicines12061254.


Identification and functional analysis of serine protease inhibitor gene family of (Wolff).

Zhang M, Dai Z, Chen X, Qin D, Zhu G, Zhu T Front Physiol. 2023; 14:1248354.

PMID: 37795265 PMC: 10545863. DOI: 10.3389/fphys.2023.1248354.


Behavioural Indicators of Pain and Suffering in Arthropods and Might Pain Bite Back?.

Elwood R Animals (Basel). 2023; 13(16).

PMID: 37627393 PMC: 10451332. DOI: 10.3390/ani13162602.


References
1.
Rawlings N, Barrett A . Evolution of proteins of the cystatin superfamily. J Mol Evol. 1990; 30(1):60-71. DOI: 10.1007/BF02102453. View

2.
Pennington M, Czerwinski A, Norton R . Peptide therapeutics from venom: Current status and potential. Bioorg Med Chem. 2017; 26(10):2738-2758. DOI: 10.1016/j.bmc.2017.09.029. View

3.
Pineda S, Sollod B, Wilson D, Darling A, Sunagar K, Undheim E . Diversification of a single ancestral gene into a successful toxin superfamily in highly venomous Australian funnel-web spiders. BMC Genomics. 2014; 15:177. PMC: 4029134. DOI: 10.1186/1471-2164-15-177. View

4.
da Silva S, Rowan E, Albericio F, Stabeli R, Calderon L, Soares A . Animal toxins and their advantages in biotechnology and pharmacology. Biomed Res Int. 2014; 2014:951561. PMC: 4054839. DOI: 10.1155/2014/951561. View

5.
Cai Y, Wei L, Ma L, Huang X, Tao A, Liu Z . Long-acting preparations of exenatide. Drug Des Devel Ther. 2013; 7:963-70. PMC: 3771853. DOI: 10.2147/DDDT.S46970. View